Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA tissue cell type enrichment"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"
C12orf42	FLJ25323	ENSG00000179088	"Chromosome 12 open reading frame 42"	Q96LP6	12	103237591-103495978	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	11	"testis: 17.2"	"Group enriched"	"Detected in some"	14	"Early spermatids: 332.1;Late spermatids: 403.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 5.1;naive B-cell: 5.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Lung - B-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"	"Not detected"	"Not detected"													NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 41: Non-specific - Cilium assembly"	"Cluster 36: Spermatids - Spermatogenesis"				"unprognostic (9.21e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.83e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.01e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.96e-4)"	"unprognostic (4.89e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.30e-1)"
CLEC17A	FLJ45910	ENSG00000187912	"C-type lectin domain containing 17A"	Q6ZS10	19	14583084-14612035	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 6.6;lymphoid tissue: 18.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 21.7;Early spermatids: 4.3;Late spermatids: 11.5;Microglial cells: 2.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"memory B-cell: 21.5;naive B-cell: 43.1"	"Lineage enriched"	"Detected in many"	14	"B-cells: 43.1"	"Cancer enriched"	"Detected in some"	8	"lymphoma: 13.9"	"Lung - B-cells, Prostate - T-cells, Testis - Late spermatids"					"Not detected"	"Not detected"									NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 62: B-cells - B-cell activation"				"unprognostic (4.71e-5)"	"unprognostic (1.34e-2)"	"unprognostic (9.64e-4)"	"unprognostic (5.02e-3)"	"unprognostic (3.90e-1)"	"unprognostic (9.00e-4)"	"unprognostic (3.18e-3)"	"unprognostic (1.60e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.78e-2)"	"unprognostic (4.43e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.65e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.23e-1)"
CNR2	CB2	ENSG00000188822	"Cannabinoid receptor 2"	P34972	1	23870515-23913362	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.4;lymphoid tissue: 8.8"	"Cell type enriched"	"Detected in some"	4	"B-cells: 35.7"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 2.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"basophil: 49.3;eosinophil: 35.1;memory B-cell: 29.6;naive B-cell: 27.9;NK-cell: 19.4"	"Group enriched"	"Detected in many"	9	"B-cells: 29.6;granulocytes: 49.3;NK-cells: 19.4"	"Group enriched"	"Detected in some"	12	"Leukemia: 2.9;lymphoma: 5.6"	"Lung - B-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB009719	Uncertain					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"CAB009719: AB_2082784"	"unprognostic (9.45e-4)"	"unprognostic (5.40e-3)"	"unprognostic (8.50e-3)"	"unprognostic (8.19e-3)"	"unprognostic (3.55e-3)"	"unprognostic (9.34e-6)"	"unprognostic (5.58e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.75e-2)"	"unprognostic (4.91e-2)"
FCRL2	"CD307b, FCRH2, IRTA4, SPAP1"	ENSG00000132704	"Fc receptor like 2"	Q96LA5	1	157745733-157777132	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"intestine: 20.9;lymphoid tissue: 34.3"	"Group enriched"	"Detected in some"	20	"B-cells: 74.6;Plasma cells: 45.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	34	"memory B-cell: 29.7;naive B-cell: 18.4"	"Lineage enriched"	"Detected in single"	42	"B-cells: 29.7"	"Group enriched"	"Detected in some"	82	"lymphoma: 15.4;Myeloma: 5.6"	"Breast - Plasma cells, Lung - B-cells"															NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"				"unprognostic (3.94e-3)"	"unprognostic (1.47e-3)"	"unprognostic (3.49e-2)"	"unprognostic (3.69e-3)"		"unprognostic (5.11e-5)"	"unprognostic (1.67e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.19e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.19e-2)"	"unprognostic (4.60e-7)"	"unprognostic (2.89e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.48e-1)"
NIBAN3	"BCNP1, FAM129C, FLJ39802"	ENSG00000167483	"Niban apoptosis regulator 3"	Q86XR2	19	17523301-17553839	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"bone marrow: 15.4;intestine: 16.6;lymphoid tissue: 34.7"	"Group enriched"	"Detected in some"	37	"B-cells: 140.9;dendritic cells: 228.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	379	"memory B-cell: 31.9;naive B-cell: 52.1;plasmacytoid DC: 110.7"	"Group enriched"	"Detected in many"	476	"B-cells: 52.1;dendritic cells: 110.7"	"Group enriched"	"Detected in some"	61	"Leukemia: 40.6;lymphoma: 90.8"	"Adipose visceral - T-cells, Breast - T-cells, Lung - B-cells, Thyroid - T-cells"	"Not detected"	"Not detected"							HPA043277	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	"Nucleoplasm, Cytosol"		"HPA043277: AB_10794391"	"unprognostic (6.55e-5)"	"unprognostic (3.03e-7)"	"unprognostic (3.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-4)"	"unprognostic (3.79e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.47e-4)"	"unprognostic (8.42e-2)"	"unprognostic (5.51e-5)"	"unprognostic (3.39e-1)"	"unprognostic (9.03e-3)"	"unprognostic (6.08e-2)"	"unprognostic (7.56e-3)"
P2RX5	"LRH-1, P2X5"	ENSG00000083454	"Purinergic receptor P2X 5"	Q93086	17	3672199-3696240	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 24.7;lymphoid tissue: 78.2"	"Group enriched"	"Detected in some"	4	"B-cells: 115.4;Plasma cells: 31.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"memory B-cell: 76.4;naive B-cell: 84.8"	"Lineage enriched"	"Detected in many"	20	"B-cells: 84.8"	"Cancer enhanced"	"Detected in many"		"lymphoma: 60.7;Myeloma: 38.7"	"Breast - Plasma cells, Lung - B-cells, Thyroid - Plasma cells"									"HPA021948, HPA067827"	Supported		Supported	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	Cytosol		"HPA021948: AB_1854878, HPA067827: AB_2685908"	"unprognostic (1.08e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.33e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.99e-8)"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.63e-2)"